Further studies validated the carcinogenic potential of pks-positive E. coli (pks+ E. coli) by demonstrating an enrichment of the pks island in the colonic mucosa of patients with CRC and inflammatory bowel disease (IBD). This evidence concerns the gene ARAF and inflammatory bowel disease.